We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Longer Ischemic Intervals During Liver Surgery Do No Harm

By HospiMedica International staff writers
Posted on 11 Jan 2011
Doubling intermittent ischemic periods to occlude hepatic blood flow for 30 minutes during surgery do not worsen hepatocellular injury, according to a new study.

Researchers at Maastricht University (The Netherlandsl) conducted a randomized trial to compare hepatocellular injury--reflected by liver fatty acid-binding protein (L-FABP)--in 20 patients undergoing liver resection with intermittent Pringle maneuver (IPM), using 15 or 30 minutes ischemic intervals. More...
The patients were randomly assigned to IPM with 15 or 30 minutes of ischemic intervals; 10 patients not requiring IPM served as controls. The primary endpoint was hepatocellular injury during liver surgery, reflected by systemic L-FABP plasma levels.

The results showed that the IPM groups had similar characteristics. Aminotransferases did not differ significantly between the 15-minute and the 30-minute groups at any time point. L-FABP levels rose up to 1853 ± 708 ng/mL in the 15-minute group and 3662 ± 1355 ng/mL in the 30-minute group after finishing liver transaction, and decreased rapidly thereafter. There were no significant differences between groups in cumulative L-FABP level, or L-FABP level at any time point. Blood loss, remnant liver function, and morbidity were comparable. Cumulative ischemia times were statistically similar in the two study groups, at an average of 34 minutes in the 15-minute group and 51 minutes in the 30-minute group. The study was published in early online on December 10, 2010, in the Journal of Hepatology.

"The current study was novel because instead of using alanine and aspartate aminotransferases to assess remnant function, it used a more sensitive marker of liver damage called liver fatty acid-binding protein,” said Cornelis Dejong, MD, and colleagues of the departments of surgery and nutrition and toxicology research. "The present study confirms the results of earlier trials, suggesting that IPM with 30 minutes ischemic intervals may be used.”

The Pringle maneuver is used in some abdominal operations. A large hemostat is used to clamp the hepatoduodenal ligament interrupting the flow of blood through the hepatic artery and the portal vein, and thus helping to control bleeding from the liver.

Related Links:
Maastricht University



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.